MIDAS PHARMA GMBH

Italy

All drugs from this manufacturer

  • RANIBIZUMAB MIDAS

    It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy, diabetic macular edema, or retinal vein occlusion.

    Dosage form: solution for injection

    Active substance Dosage
    ranibizumab -

    ATC: S01LA04

  • It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).

    Dosage form: solution for injection

    Active substance Dosage
    ranibizumab -

    ATC: S01LA04